Abstract:The enormous dynamic range of human bodily fluid proteomes poses a significant challenge for current MS-based proteomics technologies as it makes it especially difficult to detect low abundance proteins in human biofluids such as blood plasma, which is an essential aspect for successful biomarker discovery efforts. Here we present a novel tandem IgY12-SuperMix immunoaffinity separation system for enhanced detection of low abundance proteins in human plasma. The tandem IgY12-SuperMix system separates similar to 60 abundant proteins from the low abundance proteins in plasma, allowing for significant enrichment of low abundance plasma proteins in the SuperMix flow-through fraction. High reproducibility of the tandem separations was observed in terms of both sample processing recovery and LC-MS/MS identification results based on spectral count data. The ability to quantitatively measure differential protein abundances following application of the tandem separations was demonstrated by spiking six non-human standard proteins at three different levels into plasma. A side-by-side comparison between the SuperMix flow-through and IgY12 flow-through samples analyzed by both one- and two-dimensional LC-MS/MS revealed a 60-80% increase in proteome coverage as a result of the SuperMix separations, suggesting significantly enhanced detection of low abundance proteins. A total of 695 plasma proteins were confidently identified in a single analysis ( with a minimum of two peptides per protein) by coupling the tandem separation strategy with two-dimensional LC-MS/MS, including 42 proteins with reported normal concentrations of similar to 100 pg/ml to 100 ng/ml. The concentrations of two selected proteins, macrophage colony-stimulating factor 1 and matrix metalloproteinase-8, were independently validated by ELISA as 202 pg/ml and 12.4 ng/ml, respectively. Evaluation of binding efficiency revealed that 45 medium abundance proteins were efficiently captured by the SuperMix column with > 90% retention. Taken together, these results illustrate the potential broad utilities of this tandem IgY12-SuperMix strategy for proteomics applications involving human biofluids where effectively addressing the dynamic range challenge of the specimen is imperative. Molecular & Cellular Proteomics 7: 1963-1973, 2008.

Peptide and protein quantification using automated immuno-MALDI (iMALDI)

[Flecainide. A new anti-arrhythmic agent].

Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy

Semi-Quantitative MALDI Measurements of Blood-Based Samples for Molecular Diagnostics

Quantitative Proteomic Analysis Using a MALDI Quadrupole Time-of-Flight Mass Spectrometer

Single Peptide-Based Protein Identification in Human Proteome Through MALDI-TOF MS Coupled with Amino Acids Coded Mass Tagging

Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications

Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells

LC–MS/MS for protein and peptide quantification in clinical chemistry

Application of matrix-assisted laser desorption ionization time of flight mass spectrometry on the quality study of biomacromolecules

MALDI HiPLEX-IHC: multiomic and multimodal imaging of targeted intact proteins in tissues

Analysis of the Differentially Expressed Low Molecular Weight Peptides in Human Serum Via an N-terminal Isotope Labeling Technique Combining Nano-Liquid Chromatography/matrix-Assisted Laser Desorption/ionization Mass Spectrometry

Detection and quantitation of host cell proteins in monoclonal antibody drug products using automated sample preparation and data-independent acquisition LC-MS/MS

Noncovalent Antibody Immobilization on Porous Silicon Combined with Miniaturized Solid-Phase Extraction (SPE) for Array Based Immunomaldi Assays.

Targeted Quantification of Peptides Using Miniature Mass Spectrometry.

Direct Analysis and Identification of Proteins in Mixtures by LC/MS/MS and Database Searching at the Low-Femtomole Level

Peptide and protein analysis with mass spectrometry

Development of high throughput dispersive LC-ion mobility-TOFMS techniques for analysing the human plasma proteome.

MIMAS: microfluidic platform in tandem with MALDI mass spectrometry for protein quantification from small cell ensembles

Rapid Tryptic Peptide Mapping of Human Serum Albumin Using DI-MS/MSALL.

Identification of Microorganisms by Liquid Chromatography-Mass Spectrometry (LC-MS1) and in Silico Peptide Mass Libraries